BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 35305106)

  • 1. GBAS Regulates the Proliferation and Metastasis of Ovarian Cancer Cells by Combining with eEF1A1.
    Ning X; Shi G; Ren S; Liu S; Ding J; Zhang R; Li L; Xie Q; Xu W; Meng F; Ma R
    Oncologist; 2022 Feb; 27(1):e64-e75. PubMed ID: 35305106
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MicroRNA-23a depletion promotes apoptosis of ovarian cancer stem cell and inhibits cell migration by targeting DLG2.
    Zhuang RJ; Bai XX; Liu W
    Cancer Biol Ther; 2019; 20(6):897-911. PubMed ID: 30862230
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circ_0078607 inhibits the progression of ovarian cancer via regulating the miR-32-5p/SIK1 network.
    Jin Y; Wang H
    J Ovarian Res; 2022 Jan; 15(1):3. PubMed ID: 34983607
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long noncoding RNA TUG1 facilitates cell ovarian cancer progression through targeting MiR-29b-3p/MDM2 axis.
    Yang X; Xin N; Qu HJ; Wei L; Han Z
    Anat Rec (Hoboken); 2020 Dec; 303(12):3024-3034. PubMed ID: 31930662
    [TBL] [Abstract][Full Text] [Related]  

  • 5. M2-like tumor-associated macrophages-secreted EGF promotes epithelial ovarian cancer metastasis via activating EGFR-ERK signaling and suppressing lncRNA LIMT expression.
    Zeng XY; Xie H; Yuan J; Jiang XY; Yong JH; Zeng D; Dou YY; Xiao SS
    Cancer Biol Ther; 2019; 20(7):956-966. PubMed ID: 31062668
    [No Abstract]   [Full Text] [Related]  

  • 6. Long non-coding RNA SNHG1 stimulates ovarian cancer progression by modulating expression of miR-454 and ZEB1.
    Wu Y; Zhu B; Yan Y; Bai S; Kang H; Zhang J; Ma W; Gao Y; Hui B; Li R; Zhang X; Ren J
    Mol Oncol; 2021 May; 15(5):1584-1596. PubMed ID: 33641229
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanism of MicroRNA-375 Promoter Methylation in Promoting Ovarian Cancer Cell Malignancy.
    Shu J; Xiao L; Yan S; Fan B; Zou X; Yang J
    Technol Cancer Res Treat; 2021; 20():1533033820980115. PubMed ID: 33928819
    [TBL] [Abstract][Full Text] [Related]  

  • 8. F-Box and Leucine-Rich Repeat Protein 20 (FBXL20), Negatively Regulated by microRNA (miR)-195-5p, Accelerates the Malignant Progression of Ovarian Cancer.
    Wu D; Liu C; Hong L
    Mol Biotechnol; 2021 Dec; 63(12):1235-1243. PubMed ID: 34338995
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long non-coding RNA FEZF1-AS1 induced progression of ovarian cancer via regulating miR-130a-5p/SOX4 axis.
    Sun Z; Gao S; Xuan L; Liu X
    J Cell Mol Med; 2020 Apr; 24(7):4275-4285. PubMed ID: 32135030
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LncRNA FGD5-AS1 promotes the malignant phenotypes of ovarian cancer cells via targeting miR-142-5p.
    Aichen Z; Kun W; Xiaochun S; Lingling T
    Apoptosis; 2021 Jun; 26(5-6):348-360. PubMed ID: 33974163
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long non-coding RNA EPB41L4A-AS2 suppresses progression of ovarian cancer by sequestering microRNA-103a to upregulate transcription factor RUNX1T1.
    Sun T; Yang P; Gao Y
    Exp Physiol; 2020 Jan; 105(1):75-87. PubMed ID: 31645082
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Downregulation of GBAS regulates oral squamous cell carcinoma proliferation and apoptosis via the p53 signaling pathway.
    Wang X; Bai Y; Han Y; Meng J; Liu H
    Onco Targets Ther; 2019; 12():3729-3742. PubMed ID: 31190874
    [No Abstract]   [Full Text] [Related]  

  • 13. MiRNA-802 suppresses proliferation and migration of epithelial ovarian cancer cells by targeting YWHAZ.
    Yang B; Sun L; Liang L
    J Ovarian Res; 2019 Oct; 12(1):100. PubMed ID: 31640760
    [TBL] [Abstract][Full Text] [Related]  

  • 14. lncRNA MEG3 modified epithelial-mesenchymal transition of ovarian cancer cells by sponging miR-219a-5p and regulating EGFR.
    Wang L; Yu M; Zhao S
    J Cell Biochem; 2019 Oct; 120(10):17709-17722. PubMed ID: 31161607
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNA-545 suppresses progression of ovarian cancer through mediating PLK1 expression by a direct binding and an indirect regulation involving KDM4B-mediated demethylation.
    Zhang H; Zhang K; Xu Z; Chen Z; Wang Q; Wang C; Cui J
    BMC Cancer; 2021 Feb; 21(1):163. PubMed ID: 33588776
    [TBL] [Abstract][Full Text] [Related]  

  • 16. S100A7 Regulates Ovarian Cancer Cell Metastasis and Chemoresistance Through MAPK Signaling and Is Targeted by miR-330-5p.
    Lin M; Xia B; Qin L; Chen H; Lou G
    DNA Cell Biol; 2018 May; 37(5):491-500. PubMed ID: 29485916
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The miRNA mir-582-3p suppresses ovarian cancer progression by targeting AKT/MTOR signaling
    Dai T; Liang J; Liu W; Zou Y; Niu F; Li M; Zhang H; Li C; Fan M; Cui G
    Bioengineered; 2021 Dec; 12(2):10771-10781. PubMed ID: 34793263
    [TBL] [Abstract][Full Text] [Related]  

  • 18. miR‑26a inhibits ovarian cancer cell proliferation, migration and invasion by targeting TCF12.
    Gao S; Bian T; Su M; Liu Y; Zhang Y
    Oncol Rep; 2020 Jan; 43(1):368-374. PubMed ID: 31789414
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MiRNA-8073 targets ZnT1 to inhibit malignant progression of ovarian cancer.
    Zhang L; Wang YH; Wang L
    Eur Rev Med Pharmacol Sci; 2019 Jul; 23(14):6062-6069. PubMed ID: 31364107
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long noncoding RNA WDFY3-AS2 suppresses tumor progression by acting as a competing endogenous RNA of microRNA-18a in ovarian cancer.
    Li W; Ma S; Bai X; Pan W; Ai L; Tan W
    J Cell Physiol; 2020 Feb; 235(2):1141-1154. PubMed ID: 31347170
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.